A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure
Condition(s):Growth Failure; Congenital Heart DiseaseLast Updated:December 8, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Growth Failure; Congenital Heart DiseaseLast Updated:December 8, 2020Completed
Condition(s):Ataxia Telangiectasia; Growth FailureLast Updated:July 5, 2010Unknown status
Condition(s):Chronic Kidney DiseaseLast Updated:March 25, 2008Terminated
Condition(s):Faltering GrowthLast Updated:August 25, 2022Recruiting
Condition(s):Infants Aged One Month to 2 Years , Infants With Any Type of Feeding (Breast or Artificial or Weaned Attend Assiut University Children Hospital )Last Updated:September 15, 2017Unknown status
Condition(s):Failure to ThriveLast Updated:July 25, 2017Completed
Condition(s):Failure to ThriveLast Updated:October 11, 2019Terminated
Condition(s):Growth Failure; X-linked Severe Combined Immunodeficiency (XSCID); Growth Hormone ResistenceLast Updated:July 3, 2015Terminated
Condition(s):Lysosomal Acid Lipase Deficiency; Wolman DiseaseLast Updated:January 30, 2019Completed
Condition(s):Failure to Thrive; InfectionsLast Updated:October 4, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.